AUB
Atlantic Union Bankshares Corporation
AUB's fundamentals are strong: revenue grew 29% and its operating margin rose 21 points to 43%. At 11x earnings, it's trading below its usual 13x. Analysts expect earnings growth.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
AUB Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
AUB's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like AUB.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
AUB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 9.9x | $39.49 | — |
| Cheap | 11x | $39.88 | +1% |
| Current | 11x | $39.49 | — |
| Fair | 13x | $47.62 | +21% |
| Expensive | 17x | $62.29 | +58% |
Historical ranges are pointers, not guarantees.
AUB's PE is in its cheap range at 11x. If earnings grow as analysts expect, today's price would be 9.9x next year's earnings.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
AUB Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect AUB's earnings to grow and its profitability to improve, with its revenue holding steady.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
AUB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.99 | +9.2% |
| Q3 2026 | $3.65 | +101% |
| Q2 2026 | $3.34 | +66% |
| Q1 2026 | $2.35 | +9.8% |
| Q4 2025 | $2.03 | -9.4% |
| Q3 2025 | $1.82 | -24% |
| Q2 2025 | $2.01 | -11% |
| Q1 2025 | $2.14 | -21% |
| Q4 2024 | $2.24 | -11% |
AUB has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
AUB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $383.2M | +3.3% |
| Q2 2026 | $415.4M | +3.1% |
| Q1 2026 | $367.2M | +72% |
| Q4 2025 | $387.2M | +77% |
| Q3 2025 | $371M | +71% |
| Q2 2025 | $402.9M | +93% |
| Q1 2025 | $213.3M | +23% |
| Q4 2024 | $218.5M | +19% |
AUB's revenue has grown year over year for 11 quarters in a row: $383M last quarter, up 3.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 45% | +14 points |
| Q2 2026 | 49% | +45 points |
| Q1 2026 | 42% | +13 points |
| Q4 2025 | 37% | +4 points |
| Q3 2025 | 31% | -11 points |
| Q2 2025 | 4.3% | -13 points |
| Q1 2025 | 29% | -5.7 points |
| Q4 2024 | 33% | -3.8 points |
AUB has the edge over IREN on profitability, with a higher operating margin.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
AUB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $182.5M | +16% |
| Q2 2026 | $150.2M | -92% |
| Q1 2026 | $127.3M | +105% |
| Q4 2025 | $114.5M | +16% |
| Q3 2025 | $156.9M | +132% |
| Q2 2025 | $1.9B | +2123% |
| Q1 2025 | $62M | +8.8% |
| Q4 2024 | $98.3M | +103% |
AUB has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
AUB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.5% | -679K shares |
| 1 year | -0.2% | -345K shares |
| 3 years | +89% | +66.6M shares |
| 5 years | +86% | +65.3M shares |
| Available history | +76% | +61.4M shares |
AUB has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $62.5M |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $23.2M |
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
AUB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.0x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 0.2x | Very low |
| Q2 2025 | -2.4x | Net Cash |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.6x | Very low |
AUB's net debt is about 1.2 years of its operating earnings (EBITDA), up from less than a year a year ago. Net leverage isn't a meaningful measure for financial services companies like AUB.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
AUB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.5 | Neutral |
| Stochastic | 38.8 | Neutral |
AUB's weekly RSI is 50 (neutral) and its Stochastic is 39 (neutral).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
AUB PE vs Financial Services Sector
| Metric | AUB | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 13x | 17% below |
| PE % | 13 | 63 | 50 pts below |
AUB is trading at 11x earnings, a 17% discount to the Financial Services sector's median of 13x.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
AUB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $38.9 | 1.4% above |
| 20 week MA | $40.5 | 2.4% below |
| 50 week MA | $38.8 | 1.9% above |
| 100 week MA | $35.9 | 10% above |
| 200 week MA | $34.8 | 13% above |
AUB has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
AUB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $37.9 | $32.9 | -13% |
| 2021 | $32.9 | $37.4 | +14% |
| 2022 | $37.4 | $34.9 | -6.7% |
| 2023 | $34.9 | $36.5 | +4.6% |
| 2024 | $36.5 | $38.1 | +4.2% |
| 2025 | $38.1 | $36.4 | -4.4% |
| 2026 YTD | $36.4 | $39.5 | +8.5% |
AUB has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.